Comorbidity and its change predict survival in incident dialysis patients

被引:85
作者
Miskulin, DC
Meyer, KB
Martin, AA
Fink, NE
Coresh, J
Powe, NR
Klag, MJ
Levey, AS
机构
[1] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA
[2] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
关键词
case-mix adjustment; risk assessment;
D O I
10.1053/ajkd.2003.50034
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Few studies have performed a comprehensive comparison of the prognostic importance of comorbidity to that of other case-mix factors influencing incident dialysis patients' survival. Longitudinal change in the comorbid illness burden of incident dialysis patients has not been measured. Comorbidity severity and its change may serve as important prognostic markers of survival, independent of other case-mix factors. Methods: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease Cohort Study used the Index of Coexistent Disease (ICED) to assess comorbidity at the initiation of chronic dialysis treatment (1,039 incident patients) and during follow-up (733 patients). Using proportional hazards regression analyses, the relationship to survival of baseline ICED level and change in ICED level was examined. Results: At the initiation of chronic dialysis treatment, 36% of patients were at ICED level 0 to 1 (least comorbidity severity); 35%, level 2; and 29%, level 3. After multivariable adjustment, baseline ICED level was the strongest predictor of subsequent mortality. Compared with ICED level 0 to 1, relative risks for mortality were 1.9 (95% confidence interval, 1.3 to 2.6) for ICED level 2 and 2.8 (95% confidence interval, 2.0 to 3.9) for ICED level 3. The prevalence and severity of most comorbid conditions increased during follow-up. After controlling for baseline ICED level and other factors, change in ICED level over time was significantly associated with mortality (P = 0.01). Conclusion: Indexing comorbidity when patients begin chronic dialysis therapy and recording the evolution of index scores yields a predictor of mortality risk that is independent of other case-mix factors.
引用
收藏
页码:149 / 161
页数:13
相关论文
共 35 条
[1]   A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients [J].
Beddhu, S ;
Bruns, FJ ;
Saul, M ;
Seddon, P ;
Zeidel, ML .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (08) :609-613
[2]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[3]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[4]   CHANGING RISK FACTOR DEMOGRAPHICS IN END-STAGE RENAL-DISEASE PATIENTS ENTERING HEMODIALYSIS AND THE IMPACT ON LONG-TERM MORTALITY [J].
COLLINS, AJ ;
HANSON, G ;
UMEN, A ;
KJELLSTRAND, C ;
KESHAVIAH, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (05) :422-432
[5]  
Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465
[6]   UREA INDEX AND OTHER PREDICTORS OF HEMODIALYSIS PATIENT SURVIVAL [J].
COLLINS, AJ ;
MA, JZ ;
UMEN, A ;
KESHAVIAH, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :272-282
[7]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[8]  
2-B
[9]   PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE [J].
FEINSTEIN, AR .
JOURNAL OF CHRONIC DISEASES, 1970, 23 (07) :455-+
[10]   Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients [J].
Fleischmann, E ;
Teal, N ;
Dudley, J ;
May, W ;
Bower, JD ;
Salahudeen, AK .
KIDNEY INTERNATIONAL, 1999, 55 (04) :1560-1567